Final answer:
The rule-making authority for generic substitution in New Jersey is the New Jersey Board of Pharmacy, which follows FDA guidelines to ensure the safe and effective substitution of generic drugs.
Step-by-step explanation:
The rule-making authority for generic substitution of drugs in New Jersey is under the purview of the New Jersey Board of Pharmacy. This board sets the regulations for pharmacists in the state regarding when and how generic drugs can be substituted for brand-name drugs. The U.S. Food and Drug Administration (FDA) has established the criteria for therapeutic equivalence, which generally allows for the substitution of generic drugs that meet certain standards. The New Jersey Board of Pharmacy follows these guidelines and implements state-specific regulations to manage the substitution process and ensure the safety and efficacy of generic drugs dispensed in New Jersey.